文献速递真菌感染医院感染防控

糖皮质激素治疗非HIV免疫抑制隐球菌脑膜炎感染后炎症综合征的长期结局

Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case Series.
PubMed 文献 · J Infect Dis · 2026-01-01

该多中心病例系列纳入13例非HIV免疫抑制隐球菌脑膜炎后发生感染后炎症反应综合征(PIIRS)的患者,比较糖皮质激素治疗前后的临床、脑脊液和影像学指标。3例死亡,其中1例死于激素启动后的脓毒症。

要点

  • 非HIV免疫抑制CM患者发生PIIRS时,糖皮质激素可改善神经功能与脑脊液炎症。
  • 所有患者PIIRS诊断后培养阴性,但激素治疗期间仍需警惕感染等致命并发症。

核心结论

  • 糖皮质激素与CM后PIIRS的非HIV免疫抑制患者神经状态及神经炎症改善相关,支持其作为挽救治疗的潜在作用。

研究设计与样本

  • 多中心病例系列,纳入2018年7月至2025年4月期间13例非HIV免疫抑制的隐球菌脑膜炎后发生PIIRS的患者。
  • 比较PIIRS诊断时与糖皮质激素治疗后随访的临床特征、Karnofsky评分、脑脊液参数及MRI表现。

主要发现

  • 所有患者均有中枢神经系统炎症证据,包括脑脊液异常、MRI异常及精神状态改变或视力/听力丧失等神经症状。
  • 10例存活患者神经症状均消失;脑脊液白细胞计数、蛋白及脑脊液/血清葡萄糖比值在1个月时显著改善;脑MRI呈改善趋势。
  • 所有患者PIIRS诊断后培养均阴性;3例死亡,分别死于酒精性肝硬化并发症、系统性红斑狼疮及免疫抑制背景下的肝衰竭、以及启动糖皮质激素后的脓毒症。

临床怎么用

  • 对非HIV免疫抑制CM患者出现PIIRS时,可考虑糖皮质激素作为挽救治疗,但需个体化评估感染风险。
  • 治疗期间应监测神经功能、脑脊液炎症参数及MRI变化,并警惕脓毒症等致命并发症。

局限性

  • 样本量小(13例),为病例系列设计,缺乏对照组,无法确立因果关联。
  • 原文指出需系统数据收集或随机试验以更好指导糖皮质激素使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Post-infectious inflammatory response syndrome (PIIRS) is recognized as a cause of neurologic deterioration in previously healthy patients with cryptococcal meningoencephalitis (CM). However, data on non-human immunodeficiency virus (HIV), immunosuppressed patients remain limited. METHODS: Between July 2018 and April 2025, 13 non-HIV immunosuppressed patients with CM who subsequently developed PIIRS were included. Clinical features, Karnofsky performance scores, cerebrospinal fluid (CSF) parameters, and magnetic resonance imaging (MRI) findings were compared at PIIRS diagnosis and during follow-up after corticosteroid therapy. RESULTS: All patients showed evidence of CNS inflammation, including abnormal CSF, MRI findings, and neurological symptoms such as altered mental status or visual/hearing loss. Corticosteroid therapy was associated with significant improvements in Karnofsky scores at 1 month (P = .001), with sustained benefit at 6 and twelve months (P = .002); all 10 surviving patients demonstrated resolution of neurological symptoms. CSF inflammatory parameters including white blood cell (WBC) count, protein, and CSF/serum glucose ratio also significantly improved at 1 month. Brain MRI findings also showed a trend toward improvement. All patients remained culture-negative post-PIIRS diagnosis. Three patients died: 1 from complications of alcoholic cirrhosis, the second from liver failure in the setting of systemic lupus erythematosus and immunosuppression, and the third from sepsis after initiation of corticosteroids. CONCLUSIONS: Corticosteroids were associated with improvement in neurological status and neuroinflammation in non-HIV, immunosuppressed patients with PIIRS following CM. These findings support its potential role as salvage therapy in this population and highlight the need for systematic data collection or randomized trials to better guide corticosteroid use.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ito Y, Hoeltermann TA, Anjum S, et al. Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case Series. J Infect Dis. 2026. PMID: 41486473. doi:10.1093/infdis/jiaf620

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。